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Abstract
The aim of this study was to examine the
protein expression profiles of persistent Chlamy-
dia pneumoniae by two-dimensional polyacry-
lamide gel electrophoresis (2D PAGE) and
surface-enhanced laser desorption ionization
time-of-flight mass spectrometry (SELDI-TOF-
MS). Although 2D PAGE is still the method of
choice for separating and detecting compo-
nents of complex protein mixtures, it has
several distinct disadvantages; i.e., being labor-
intensive and having a bias toward proteins
within the dynamic range of the gel condition.
Hence, SELDI-TOF-MS technology was used to
complement 2D PAGE. C. pneumoniae-infected
HEp2 cells were treated with or without IFN-γ,
and protein expression profiles were deter-
mined at 48 h postinfection (hpi). Unfraction-
ated monolayers were also used for protein
profiling by SELDI-TOF, using two different
chip surface types: weak cation exchanger and
hydrophobic surface. Under IFN-γ-induced per-
sistence, C. pneumoniae expresses an altered pro-
tein expression profile. Twenty chlamydial
proteins showed differential regulatory patterns
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Introduction
Chlamydia pneumoniae is a Gram-negative
obligate intracellular pathogen which has a
complex biphasic developmental cycle and
causes both acute and chronic respiratory
infections. Recently, it has been implicated in
chronic human disease, specifically athero-
sclerosis (1–5). The developmental cycle of
Chlamydia initiates when infectious, but
metabolically inactive, elementary bodies (EB)
enter eukaryotic host cells and differentiate
into metabolically active reticulate bodies
(RB). The RB then divides by binary fission
and subsequently redifferentiates to EB, and are
released from the host cell to initiate another
lytic cycle (6–10). In vitro, the chlamydial
developmental cycle may be induced into a
non-lytic (persistent) phase by IFN-γ (11). A
subinhibitory concentration of IFN-γ can lead
to a state in which redifferentiation of RB to
infectious EB is interrupted and the RB
develop into an arrested growth stage, com-
monly known as an aberrant body (AB). Even
though it maintains viability while inside the
host cell, it is non-culturable and therefore,
results in a long-term relationship within the
host cells (11,12).
Although our understanding of Chlamydial
persistence at the molecular level is still at its
infancy, considerable progress has been made
in the recent years. The availability of genome
sequences of the chlamydial species (13–15),
as well as the progress made in quantitative
RT-PCR, microarray, and proteomics (16–24),
have provided some significant insight into
differential expression profiles of the genes/
proteins which will help in understanding the
common biological properties of this unique
pathogen.
We recently reported an analysis of protein
expression patterns of C. pneumoniae under
IFN-γ-induced persistence by employing two-
dimensional polyacrylamide gel electropho-
resis (2D PAGE), MALDI-TOF-MS and one 
of the advanced proteomic analysis tools,
PDQuest™ software for quantification (19).
This technique is not only labor-intensive, but
also limits the isolation of low-abundant,
highly hydrophobic membrane proteins, and
also those with iso-electric points at either
extreme of the pH scale. Moreover, it requires
a large amount of protein for analysis, which
could be problematic, particularly with clini-
cal samples. Because of difficulties in the
study of proteins involved in Chlamydial per-
sistence, as an extension of our previous study,
we looked for other high through-put tech-
nologies to integrate with existing techniques
to better understand the global protein expres-
sion profile.
An alternative to 2D PAGE is surface-
enhanced laser desorption ionization time-
of-flight mass spectrometry (SELDI-TOF-MS),
which involves analysis of protein mixtures
without the need for an initial protein separa-
tion process. This proteomic approach combines
the strategy of bio-affinity or chromatographic
chemistry with mass spectrometry to identify
the selectively captured proteins. It provides
spectra of differentially expressed proteins, com-
parison of which could directly classify the
by SELDI-TOF-MS, two of which, HSP-70
cofactor, and a hypothetical protein, were iden-
tified by 2D PAGE and mass spectrometry.
Two additional proteins, phosphatidylserine
decarboxylase and 30S ribosomal protein S17,
were exclusively identified by SELDI TOF-MS
analysis, as these were not present in sufficient
quantity for detection by 2D PAGE. We pro-
pose that a combination of 2D-PAGE and
SELDI-TOF-MS may complement the disad-
vantages of each technique alone and may pro-
vide a rapid and precise screening technique.
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cellular protein content. In recent years, this
technology has been widely used in rapid
screening for a large number of potential
biomarkers in oncology (25,26), clinical diag-
nosis (27), and infectious diseases (28). With its
superior sensitivity, SELDI-TOF has been
proven as a valuable approach for microor-
ganism protein profiling with limited material
samples (29).
In this study, we have integrated the tech-
niques of 2D PAGE with SELDI-TOF-MS to
assess the utility of a combined approach for
analysis of differential protein expression pro-
files in C. pneumoniae. The rational for this
approach is that a combination of SELDI-
TOF-MS and 2D PAGE analysis would result
in each method complementing each other’s
strengths. For example, 2D PAGE allows for
simultaneous estimation of molecular weight
and iso-electric point of a given protein.
SELDI-TOF-MS, on the other hand, has a
greater dynamic range and molecular weight
estimations are more precise, with greater sen-




HEp2 cells (ATCC CCL-23) were obtained
from the American Type Culture Collection
(Rockville, MD) and maintained in Iscove’s
maintenance medium (IMM) (Cellgro, Wash-
ington, DC) supplemented with 10% (v/v)
fetal bovine serum, 2 mM L-glutamine, 1%
(v/v) nonessential amino acids, 10 mM HEPES
buffer, 10 µg/mL gentamycin, 25 µg/mL of
vancomycin. Cells were grown in 75-cm2 flasks
(Costar, Cambridge, MA) at 37°C in 5% CO2
for 24 h to achieve confluency of the mono-
layer, and harvested with Trypsin-EDTA.
Bacterial Isolate
C. pnuemoniae A-03 (ATCC VR-1452) was
previously isolated in our laboratory from an
atheroma of a patient with coronary artery
disease during heart transplantation at the
Jewish Hospital Heart and Lung Institute,
Louisville, KY (1). C. pnuemoniae were propa-
gated in HEp2 cell monolayer in Iscove’s
growth medium (IGM) as described previ-
ously (19). EBs were harvested and purified
by disruption of HEp2 cell monolayers with a
cell scraper, sonication, and centrifugation
over a renograffin density gradient (30). EB
suspensions were stored in sucrose-phos-
phate-glutamic acid buffer at –80°C.
Infection Protocol
Similar to our previous study (19), HEp-2
cells were seeded in six-well plates at 0.5 × 106
cells per well in IMM and incubated in 
5% CO2, at 37°C overnight. Cells were subse-
quently inoculated with 0.5 × 108 IFU per well
of C. pneumoniae in 2 mL of Iscove’s growth
media with or without human recombinant
IFN-γ 50 U and 100 U per milliliter (Promega,
Madison, WI), centrifuged at 675g for 1 h at
10°C, and incubated at 37°C in 5% CO2 for 24
and 48 h. For proteomic analysis, Chlamydia-
infected HEp-2 cells were pulse-labeled for 2 h
(at 22 and 46 hpi, respectively) in methion-
ine/cysteine-free RPMI 1640 medium (Cell-
gro, Herndon, VA) containing 100 µCi of [35S]
methionine/cysteine per milliliter (Redivue
Pro-mix, Amersham Pharmacia, Piscataway,
NJ) and 500 µg of cycloheximide per milliliter
in the presence or absence of IFN-γ. At the end
of the 2-h labeling period, Chlamydia-infected
HEp-2 cells were washed in cold phosphate-
buffered saline, scraped with a cell scraper,
and pelleted by centrifugation at 16,000g.
Protein Extraction
C. pneumoniae-infected HEp-2 cell pellets
were resuspended in 30 µL of buffer contain-
ing 2% (w/v) sarkosyl, 1% (w/v) OBG (Octyl
β-D-1-thioglucopyranoside), 2 mM tri-butyl
phosphine (TBP), and 5 µL protease inhibitors
(leupeptin and aprotinin). Samples were soni-
cated (Cell dismembrator, Model 100 [Fisher
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Scientific]) for 5 s, boiled for 5 min, then
cooled to room temperature. One hundred
microliters of thiourea lysis buffer (7 M urea, 
2 M thiourea, 10 mM Tris, and 2 mM TBP and
2% [v/v] ampholine) was added, followed by
the addition of 3.0 µL of a mixture of 50 mM
MgCl2, 476 mM Tris-HCl, 24 mM Tris base, 
1.0 mg of DNase-1 per milliliter, and 0.250 mg
of RNase A per milliliter (pH 8.0), incubated
on ice for 10 min and stored at –80°C.
2D Gel Electrophoresis
Radio-labeled protein extracts were mixed
with IPG (immobilized pH gradient) rehydra-
tion buffer containing 8 M urea, 4% (w/v)
CHAPS, 0.04 M Tris Base, 0.065 M DTT
(dithiothreitol), 0.01% (w/v) bromophenol
blue in a final volume of 400 µL as follows. 
(1) To generate an electrophoretic map of puri-
fied C. pneumoniae EBs, 750 µg of protein
extracts was mixed with IPG rehydration
buffer. (2) To study intracellular C. pneumoniae
protein expression, 75 µg of [35S]-labeled chlamy-
dial proteins was mixed in IPG rehydration
buffer. Protein samples were loaded onto
Immobiline™ DryStrip (IPG strips 4–7, 6–11,
or 3–10) (Amersham Biosciences, Uppsala,
Sweden), allowed to rehydrate overnight and
isoelectrofocused to 98,000 V hours in PRO-
TEAN® IEF cell (Bio-Rad). The following
focusing parameters were applied: 7000 V of
maximum voltage, 500 V of holding voltage,
50 µA of maximum current per gel, and for a
duration of 16 h. After focusing was com-
pleted, IPG strips were equilibrated in buffer
containing 6 M urea, 2% (w/v) DTT, 30%
(v/v) glycerol, and 1X Tris-acetate. The second
dimension was carried out using 10% poly-
acrylamide, 20 × 20-cm slab gels in PROTEAN
II xi multi-cell system (Bio-Rad) at 4°C for 
4.5 h under a 500-V maximum voltage and 20
W per gel, with 200 mM Tricine used as a
cathode buffer, and 0.4% (w/v) SDS plus 625
mM Tris-acetate (pH 8.3) used as an anode
buffer. Gels were fixed in 40% ethanol –7.5%
acetic acid for 30 min. Gels containing puri-
fied EB proteins were silver-stained, whereas 
gels containing radio-labeled chlamydial pro-
teins were treated for 30 min with Amplify
fluorographic reagent (Amersham Pharmacia,
Buckinghamshire, England), vacuum dried,
and exposed to high density phosphor-
imaging screens (Bio-Rad) for 2.5 d. Images
were scanned in a Molecular Imager® FX Pro
Plus™ system (Bio-Rad). This imaging equip-
ment is fully integrated to the ProteomeWorks™
system (Bio-Rad) with a high-resolution image
acquisition interface within the PDQuest
software.
Image Analysis and Identification 
of Protein Spots
Protein spots were analyzed and quantified
for differential expression patterns between
gels treated with and without IFN-γ using
PDQuest software v7.1 (Bio-Rad) as explained
previously (19). Briefly, PDQuest software v7.1
interfaced directly with the phosphor-imager
using ProteomeWorks software. Protein spots
on the untreated and IFN-γ treated gels were
aligned by the pattern recognition feature of
the software. During spot detection, the origi-
nal scanned gel image is filtered to remove
background noise, and the filtered images are
used as the basis for Gaussian modeling for
quantitative purposes. PDQuest software was
also used for quantification, in which pixel
values for each identified spot were first nor-
malized as a percentage of total pixel quantity
of all valid spots for each individual gel
image. After normalization, analytical tools in
PDQuest software were used for statistical
analysis of differential expression patterns that
allow spots to be grouped under user-defined
fold increase or decrease regulatory changes.
Protein spots from C. pneumoniae EBs were
excised from silver-stained gels and treated
with 20 µg Trypsin per milliliter in 50 mM
ammonium bicarbonate at 37°C overnight.
Two microliters of supernatant was mixed in
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an equal volume of saturated α-cyano-4-
hydroxycinnamic acid, 50% (v/v) acetonitrile,
0.1% (v/v) trifluoroacetic acid (TFA), and 
0.8 µL of the resulting solution was applied to
the MALDI-MS template. Masses of peptide
fragments were determined by MALDI–time-
of-flight (TOF) analysis with a Micromass mass
spectrometer. Patterns of measured masses were
matched against theoretical masses of proteins
found in the annotated databases SWISS-PROT
and TREMBL, accessible in the ExPASy Molec-
ular Biology server (http://expasy.cbr.nrc.ca/).
Searches were performed with the profound-
peptide mapping (The Rockefeller University
Edition v4.10.5) with restrictions to proteins
from 1 to 100 KD and mass tolerances of 
100 ppm. Partial enzymatic cleavages leaving
one cleavage site, oxidation of methionine,
and modification of cysteine with iodoac-
etamide were considered in these searches.
SELDI-TOF-MS Analysis
Weak cation exchange and hydrophobic
surface ProteinChip arrays were preequili-
brated in the binding/washing buffers of
either 100 mM sodium acetate (pH 4.0) with
0.1% Triton X-100 for cation exchange, or 50 mM
HEPES (pH 7.0) with 0.1% Triton X-100 for
hydrophobic surface. Protein extracts (25 µg
per spot) were prepared by vortexing in a
buffer containing 9 M urea, 2% CHAPS and 
50 mM Tris (pH 9.0) at 4°C for 30 min. The
samples were then diluted 40-fold with the
corresponding binding/washing buffers and
applied to the ProteinChip arrays assembled
in a bio-processor. A 96-well formatted bio-
processor reservoir system, allowing multi-
chip processing of proteins in several samples
simultaneously, was sealed and vigorously
agitated at room temperature for 30 min. This
allows the proteins to bind to the chip surface
either through charge interaction or by
reversed phase hydrophobic interaction. The
unbound proteins were washed away with the
corresponding binding/washing buffers for
three times. The arrays were rinsed with 1 mM
HEPES (pH 7.0) twice before removal from the
bio-processor. After air-drying, two additions
of 1 µL of saturated sinapinic acid were
applied to each spot of the arrays. The Pro-
teinChip was analyzed on the Protein Bio-
logical System (PBS-II) mass spectrometer
(Ciphergen). The data was automatically
collected by two sequential acquisitions, in
which, one was for the low mass range from 5
to 30 KD with a laser intensity of 220 mJ, and
another with a laser intensity of 250 to focus
on the high mass range from 30 to 80 KD. The
external calibration equation, all-in-1 protein
molecular weight standard (Ciphergen), was
applied to all spectra for calibrating the mass
accuracy. The obtained data was analyzed by
Biomarker Wizard software from Ciphergen.
Bioinformatics
Upregulated or unchanged protein peaks,
which were discovered by SELDI-TOF-MS
analysis, were identified by bioinformatics
approach using TagIdent tool (http://us.expasy.
org/tools/tagident.html). The molecular weight
(mw) and pI of such spots corresponding to
these protein peaks were also estimated from
the analytical 2D PAGE, and applied to TagI-
dent. Very stringent parameters and specified
error margins of a pI range of ±0.25 and mw
range of ±10% were used to match proteins
from the database (Swiss-Prot/TrEMBL/NCBI)
with our observed mw and pI (p-value of <0.05).
Results and Discussion
The primary objective of this study was to
integrate the two techniques of 2D PAGE and
SELDI-TOF-MS to further examine differential
expression patterns of C. pneumoniae under
IFN-γ-induced persistence. In order to assess
the validity of comparative analysis by 2D
PAGE and SELDI-TOF-MS, the accuracy of
each technique was established with known
molecular weight standards (Table 1). The
molecular weights of the seven protein
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standards (e.g., hirudin, cytochrome C, myo-
globin, carbonic anhydrase, enolase, albumin,
and IgG) were measured by SELDI-TOF-MS
as well as 2D PAGE. Additionally, the iso-
electric points of all the protein standards
were determined by 2D PAGE. The molecular
weights and iso-electric points of all seven
protein standards showed considerable corre-
lation when compared with each of the two
techniques, indicating good concordance of
SELDI-TOF-MS and 2D PAGE techniques.
Using SELDI-TOF-MS, a total of 1751 pro-
teins were detected in the three types of mono-
layers analyzed: C. pneumoniae-infected HEp2
monolayers with or without IFN-γ and unin-
fected HEp2 monolayers with IFN-γ, as a con-
trol. All monolayers were analyzed by both
hydrophobic and weak cation exchange chip
types. Twenty C. pneumoniae proteins, which
were differentially expressed and showed a 
p-value of <0.04, were further analyzed by the
combination of both the methods (Table 2).
With respect to proteins found by SELDI TOF-
MS analysis, proteins within the same range of
molecular weight were located in the 2D PAGE.
Of the 20 proteins, we confirmed the identity
of 2 C. pneumoniae proteins expressed intracel-
lularly at 48 hpi under infectious (IFN-γ
untreated) as well as IFN-γ treated (100 U/mL)
by MALDI-TOF-MS. These two proteins,
CPn0710 and GrpE, are depicted in bold in
Fig. 1 and Table 1. Both of these proteins had
p-value of <0.01, and showed differential regu-
latory pattern when induced with IFN-γ. Con-
sistent with in our previous study (19),
CPn0710 was found to be 35.4-fold down-
regulated, whereas, GrpE was upregulated by 
1.6-fold. The regulatory pattern of these two
proteins, when analyzed by SELDI-TOF-MS,
showed CPn0710 to be 1.5-fold downregulated
and GrpE 1.4 upregulated, indicating substan-
tial agreement between the two techniques.
Although function of the CPn0710, a hypo-
thetical protein, is still unknown, GrpE protein
stimulates, jointly with DnaJ, the ATPase activ-
ity of the DnaK chaperone (31,32). It accelerates
the release of ADP from DnaK thus allowing
DnaK to recycle more efficiently and therefore
may suggest its upregulation during IFN-
induced stress condition in C. pneumoniae.
For the other 18 proteins, a bioinformatics
approach was implemented by using the
TagIdent tool to locate the protein on the 2D
gel. Briefly, the information obtained on m/z
ratio by SELDI-TOF-MS analysis and the cor-
responding pI of the spots in the 2D gel
Table 1
Assessment of Standard Protein Markers Used for SELDI-TOF-MS and 2D PAGE
Theoretical values SELDI analysis 2D PAGE
Protein standards Mol. wt. pI Mol. wt. Mol. wt. pI
Hirudin BHVK (36) 7034 Varies 7475 7000 7.6–7.8
Cytochrome C (Bovine) (37) 12,230 10.37–10.8 11,550 12,000 7.6–8.2
Myoglobin (Equine) (38) 16,951 7.3 major comp. 17,134 19,000 8.0–8.4
6.8 minor comp.
Carbonic anhydrase 29,023 5.9 28,988 31,000 5.5–9.0
(Bovine RBC) (39)
Enolase (S. cervisiae) (40) 46,671 6.1 46,531 50,000 6.4–8.3
Albumin (bovine) (41) 66,433 4.7–4.9 66,379 75,000 4.0–6.2
IgG (Bovine) (Sigma, 147,300 Heterogenous 147,034 150,000 Smear
cat. no I5506)
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(Table 1; Fig. 1), provided the data for iden-
tifying the protein spots. Interestingly, out of
these 18 proteins, 2 of the proteins, PsdD and
Rs17, were discovered exclusively by SELDI-
TOF-MS analysis (highlighted in Table 1),
and which could not be resolved by 2D
PAGE. Both proteins showed a p-value of 0.02.
The fact that PsdD, a 5-kD protein, and Rs17,
a highly alkaline protein (pI = 10.41), were
detected exclusively by SELDI-TOF-MS anal-
ysis, further confirms our assumption that
coupling of these two techniques offers a dis-
tinct advantage, because proteins that are in
low abundance, low Mw, and with extreme
pI, can be very difficult to detect by 2D PAGE,
whereas, can be readily detected by SELDI-
TOF-MS.
Rs17 is a 30S ribosomal protein which is
involved in the translation process. PsdD
converts phosphatidylserine to phosphatidyl-
ethanolamine during phospholipid biosyn-
thesis in bacteria (33,34). Phospholipids are
major structural components of cell mem-
branes and also play an important role in
membrane-localized processes. Inhibition of
PsdD alters the transport activities inside the
bacterium because of altered phospholipids
composition, which not only affects phos-
pholipid synthesis, but also, other cellular
activities (35). PsdD was found remarkably
upregulated in the IFN-treated cultures. This
perhaps indicates that C. pneumoniae allows
influx of ions across the membrane and
keeps a basal level of metabolism going to
remain viable under hostile condition.
Taken together, we have shown that SELDI-
TOF-MS is a high throughput screening tool
with high sensitivity, whereas 2D PAGE is an
excellent discovery tool, which allows estima-
tion of both Mw and pI of a given protein and
also helps visualizing isoforms of certain pro-
teins. Although there is considerable correlation
between the two techniques, there are some
disagreements in the bioinformatics identifica-
tion. 2D PAGE is likely to be more accurate, as
it utilizes Mw and pI and perhaps may be
better for quantification of regulatory patterns.
We tested the combination of these two tech-
niques to study one model of C. pneumoniae
persistence. Such a combined approach could
be used in other systems as well, and may be a
valuable tool in directly measuring the protein
levels and activity within the host cell. Addi-
tionally, it may also play a role in mapping dif-
ferential protein expression profiles between
healthy and diseased individuals, which may
lead to discovery of biomarkers specific for
that disease process.
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